We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+585.67%
AUM
$117M
AUM Growth
+$1.45M
Cap. Flow
-$3.72M
Cap. Flow %
-3.18%
Top 10 Hldgs %
39.58%
Holding
96
New
11
Increased
43
Reduced
22
Closed
11
Avg Time Held
0.9 quarters
Top 10 Avg Time Held
0.8 quarters
Top 20 Avg Time Held
0.9 quarters

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$4.59M
2
HRI icon
Herc Holdings
HRI
+$2.01M
3
GNW icon
Genworth Financial
GNW
+$1.3M
4
MO icon
Altria Group
MO
+$1.04M
5
CMCSA icon
Comcast
CMCSA
+$1.03M

Sector Composition

Rank Sector Weight
1 Miscellaneous 17.73%
2 Financials 16.36%
3 Consumer Discretionary 15.24%
4 Energy 10.18%
5 Industrials 9.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BAX icon
76
Baxter International
BAX
$12.6B
$278K 0.24%
7,088
– –
2014 Q1
1 quarter
SPHY icon
77
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.8B
$271K 0.23%
+10,155
New +$268K
2014 Q2
0 quarters
AXP icon
78
American Express
AXP
$208B
$265K 0.23%
2,794
– –
2014 Q1
1 quarter
REGN icon
79
Regeneron Pharmaceuticals
REGN
$76.9B
$246K 0.21%
870
+35
+4% +$10.4K
2014 Q1
1 quarter
DHI icon
80
D.R. Horton
DHI
$37.7B
$229K 0.2%
+9,300
New +$213K
2014 Q2
0 quarters
XLK icon
81
State Street Technology Select Sector SPDR ETF
XLK
$130B
$221K 0.19%
11,504
-246
-2% -$4.55K
2014 Q1
1 quarter
MON
82
DELISTED
Monsanto Co
MON
$218K 0.19%
+1,750
New +$205K
2014 Q2
0 quarters
XLV icon
83
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$177K 0.15%
4,552
+12
+0.3% +$705
2014 Q1
1 quarter
FNFG
84
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$146K 0.12%
16,747
-54
-0.3% -$478
2014 Q1
1 quarter
TRST icon
85
Trustco Bank Corp NY
TRST
$913M
$124K 0.11%
3,701
-8
-0.2% -$266
2014 Q1
1 quarter
ADM icon
86
Archer Daniels Midland
ADM
$38.5B
– –
-9,860
Closed -$428K –
BNDX icon
87
Vanguard Total International Bond ETF
BNDX
$82.5B
– –
-9,056
Closed -$459K –
CMCSA icon
88
Comcast
CMCSA
$73.3B
– –
-41,180
Closed -$1.03M –
GILD icon
89
Gilead Sciences
GILD
$187B
– –
-64,835
Closed -$4.59M –
GNW icon
90
Genworth Financial
GNW
$3.55B
– –
-73,115
Closed -$1.3M –
HRI icon
91
Herc Holdings
HRI
$4.13B
– –
-25,138
Closed -$2.01M –
JCI icon
92
Johnson Controls International
JCI
$95.4B
– –
-5,241
Closed -$260K –
LYB icon
93
LyondellBasell Industries
LYB
$19.4B
– –
-3,550
Closed -$316K –
UAA icon
94
Under Armour
UAA
$2.12B
– –
-7,460
Closed -$214K –
CBI
95
DELISTED
Chicago Bridge & Iron Nv
CBI
– –
-5,790
Closed -$505K –
WFM
96
DELISTED
Whole Foods Market Inc
WFM
– –
-10,555
Closed -$536K –

Similar funds

Fagan Associates's Q2 2014 Portfolio in Review

As of Q2 2014, Fagan Associates held 96 positions worth $117M, up 1.3% from $115M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fagan Associates withdrew a net $3.72M in Q2 2014, closing 11 positions and reducing 22 holdings. Its most notable exit was Gilead Sciences, an estimated $4.59M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Fagan Associates opened a new position in Alphabet (Google) Class C worth $4.25M.

  • Fagan Associates's largest Q2 2014 buy was Alphabet (Google) Class C: 147,002 shares worth $4.25M.
  • Fagan Associates added most to Vanguard Global ex-US Real Estate ETF in Q2 2014, an estimated $303K increase.
  • Fagan Associates's biggest Q2 2014 reduction was Altria Group, cutting an estimated $1.04M.
  • Fagan Associates fully exited Gilead Sciences in Q2 2014, selling an estimated $4.59M.
  • Fagan Associates's ten largest holdings make up 40% of its $117M portfolio in Q2 2014.
  • Fagan Associates opened 11 new positions and closed 11 in Q2 2014.
  • Fagan Associates's portfolio value rose 1.3% quarter-over-quarter to $117M.

Based on Fagan Associates's 13F filing for Q2 2014, filed 11 Aug 2014.